Sign in
4

Changes in Ownership

PROTHENA CORP PUBLIC LTD CO Filed Acc 0001140361-23-037713

Chief Scientific Officer sold 4,000 shares at an average $67.05 ($268,182)

  • Chief Scientific Officer acquired 4,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Zago Wagner M. Chief Scientific Officer 2023-08-02 Option exercise 10b5-1 +4,000 $12.15 $48,600 4,000 D: show line 1 in the form
Zago Wagner M. Chief Scientific Officer 2023-08-02 Sale 10b5-1 −3,771 $66.98 $252,593 229 D: show line 2 in the form
Zago Wagner M. Chief Scientific Officer 2023-08-02 Sale 10b5-1 −229 $68.07 $15,589 0 D: show line 3 in the form
Open-market sales · 4,000 sh · avg $67.05 · $268,182

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Zago Wagner M. Chief Scientific Officer 2023-08-02 Option exercise · Stock Option (Right to Buy) 10b5-1 −4,000 58,000 D: show line 4 in the form
Loading xslF345X05/form4.xml…